Pharming Group NV - Company Profile
Powered by
All the data and insights you need on Pharming Group NV in one report.
- Save hours of research time and resources with
our up-to-date Pharming Group NV Strategy Report
- Understand Pharming Group NV position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Pharming Group NV Catalyst Calendar
Proactively evaluate Pharming Group NV’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Pharming Group NV Catalyst Calendar data
Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
---|---|---|---|---|---|---|---|
01 Dec 2021 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
15 Aug 2021 | Phase II Trial Completion | Pharming Group NV | PHARM | conestat alfa | Infectious Disease; Respiratory | Acute Lung Injury; Coronavirus Disease 2019 (COVID-19) | Clinical Trial Registry |
01 Jan 2021 | Phase II/III Trial Results | Pharming Group NV | PHARM | leniolisib | Genetic Disorders | PASLI Disease (Activated PI3K Delta Syndrome (APDS)) | Company Reports |
15 Sep 2020 | Phase II Trial Initiation | Pharming Group NV | PHARM | conestat alfa | Infectious Disease; Respiratory | Acute Lung Injury; Coronavirus Disease 2019 (COVID-19) | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer